NEW YORK (Reuters) – GoodRx Holdings Inc (O:) on Tuesday priced its initial public offering (IPO) at $33 per share, above its target range, according to a person familiar with the matter.
The U.S. online prescription drug platform had planned to sell 34.6 million shares in its IPO at a target range of $24 and $28 per share.
GoodRx did not immediately respond to a request for comment.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.